Health Canada has approved the oral GnRH receptor antagonist relugolix (Orgovyx ) for the treatment of patients with advanced prostate cancer.1
The approval is based on results from the ph… Read More
MADRID — Patients with previously treated small-cell lung cancer (SCLC) obtained durable responses with either of two doses of the bispecific T cell-engaging (BiTE) antibody tarlata… Read More
People living alone have a higher risk of cancer mortality. (Cancer)
Integrating an automated screening tool into an electronic health record system showed potential for identifying patien… Read More
This 27-year-old woman and her boyfriend, who is 31, have been dating for a couple of months now. And not long ago, he moved to a different state to temporarily stay with his sister.
However… Read More
The motions included lawyers for Trump arguing for a dismissal of the case. Manage newsletters View in browser Advertisement 1. Trump Files 4 Late Night Motions in Hour… Read More